Science spin: IPS cell research in the news

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 5, 2011, Pages 644-646

  Caulfield, T ^a   Rachul, C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; POLICY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SKIN CELL;

ADULT; EMBRYONIC STEM CELLS; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MASS MEDIA; SCIENCE;

EID: 79955424278     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.309     Document Type: Review

References (5)

1. Breakthrough of the year: the runners up. Science 318, 1844-1849 (2007).
2. Hyun, I., Hochedlinger, K., Jaenisch, R. & Yamanaka, S. New advances in iPS cell research do not obviate the need for human embryonic stem cells. Cell Stem Cell 1, 367-368 (2007). (Pubitemid 47506540)
3. Holden, C. & Vogel, G. A seismic shift for stem cell research. Science 319, 560-563 (2008).
4. CNN. Human skin cells reprogrammed to act like stem cells. (20 November 2007).
5. Bubela, T. et al. Science communication reconsidered. Nat. Biotechnol. 27, 514-518 (2009).